A Diversified Outreach Strategy
Is Key to Clinical Trial Inclusivity
New Infographic Available for Download
Many clinical trial sponsors are seeking ways to enable hybrid study designs with ease and confidence. Our new infographic follows the patient's journey from consideration to enrollment to engagement throughout the study life cycle, with information to help sponsors create a more diverse and inclusive participation environment.
This infographic is based on the recent Study Voice survey of 2,078 healthcare consumers and clinical trial participants. With racial and ethnic minorities representing between 2–16% of clinical trial participants,1 our data from both healthcare consumers and clinical trial participants alike displays the importance of incorporating agile enrollment and engagement support offerings for any hybrid study approach. Increasing your reach with the right mix of outreach tactics to meet various patient target demographics is key, as is preparing a strategy to remove participation barriers to ensure successful engagement.
Our guidance supports sponsors in adopting a hybrid study approach, making clinical trials accessible to all patients through dynamic solutions that respond to individualized needs and preferences.
1. Alaric Dearment, "As Precision Medicine Grows, so Does the Importance of Clinical Trial Diversity," MedCity News, July 7, 2019, https://medcitynews.com/2019/07/as-precision-medicine-grows-so-does-the-importance-of-clinical-trial-diversity/?rf=1.